C O M M U N I C A T I O N S
Table 2
Scheme 3
formation of E-isomer in a small amount. Indeed, when a smaller
phosphine, P(OEt)3, was employed in this reaction, only Z-isomer was
obtained, albeit the yield was lower. In addition, the reaction with
P(OEt)3 (finishing in one minute) was much faster than the one with
4e (finishing in ∼25 min).
In summary, a phosphine-mediated Dha formation from SNOCs
was developed. Mechanistic study suggests that this reaction proceeds
mainly via an intramolecular cis-elimination on the azaylide intermedi-
ate. This Dha formation procedure, under very mild conditions, holds
the potential to be applied for the detection of protein S-nitrosation.
Scheme 2
Acknowledgment. Financial support from the Washington State
University and American Heart Association (0930120N).
Supporting Information Available: Spectroscopic and analytical
data and selected experimental procedures. This material is available
primary RSNO compounds are unstable species, they were freshly
generated from corresponding Cys starting materials and were used
for the elimination without purification. The yields reported were
overall yields in the two steps. As shown in Table 2 (entries 1-7), all
of the SNOC derivatives provided Dha products in good yields. We
have also tested this elimination in aqueous solutions, such as pH 7.4
PBS buffer. Due to a solubility problem for both SNOC compounds
and phosphine 4e, 20% of THF was needed. As shown in entries 8-11,
the desired Dha products were again obtained in decent yields, albeit
lower than in pure THF. In addition, a homocysteine derivative 1h
was also tested in this reaction (entry 12). As expected, no Dha
formation was observed with this substrate. We believe this transfor-
mation of Cys compounds, under very mild conditions, could serve
as a method to distinguish cysteine and homocysteine.
To examine the chemoselectivity of 4e, we tested the reaction of
4e with Cys-based disulfide 5. Unlike HMPT, 4e did not react with 5
to produce any detectable Dha product. In fact, disulfides were not
very sensitive to 4e. Trace amounts of -S-S- reduction products
were observed after 3 h. Extending the reaction time to 48 h did lead
to reduction product 1a in 40-50% yield (Scheme 2).
To prove the intramolecular elimination mechanism proposed in
Scheme 1, compound 1i was prepared. Upon nitrosation and treatment
with phosphine, an azaylide intermediate should form (Scheme 3). An
intramolecular cis-elimination from an eclipsed conformation (path A)
should give a Z-alkene product 6a. In contrast, an intermolecular trans-
elimination from the staggered conformation (path B) should provide
an E-isomer 6b. When 4e was used as the phosphine reagent, the
Z-isomer 6a was obtained as the major product (54%); we also isolated
some E-isomer 6b in 27% yield. Presumably, with 4e, a large
phosphine substrate, the lower-energied staggered conformation over-
whelmed the preferred cis-elimination to some degree, leading to the
References
(1) (a) Lancaster, J. R. Nitric Oxide 2008, 19, 68. (b) Zhang, Y.; Hogg, N.
Free Radical Biol. Med. 2005, 38, 831. (c) Hess, D. T.; Matsumoto, A.;
Kim, S. O.; Marshall, H. E.; Stamler, J. S. Nat. ReV. Mol. Cell. Biol. 2005,
6, 150. (d) Foster, M. W.; McMahon, T. J.; Stamler, J. S. Trends Mol.
Med. 2003, 9, 160.
(2) For recent reviews on RSNO detection, see: (a) Gow, A.; Doctor, A.;
Mannick, J.; Gaston, B. J. Chromatogr., B. 2007, 851, 140. (b) Kettenhofen,
N. J.; Broniowska, K. A.; Keszler, A.; Zhang, Y.; Hogg, N. J. Chromatogr.,
B. 2007, 851, 152. (c) MacArthur, P. H.; Shiva, S.; Galdwin, M. T.
J. Chromatogr., B. 2007, 851, 93. (d) Jaffrey, S. R. Methods Enzymol.
2005, 396, 105. (e) Forrester, M. T.; Foster, M. W.; Benhar, M.; Stamler,
J. S. Free Radical. Biol. Med. 2009, 46, 119. For deficiencies of current
method to detect RSNO, see: (f) Giustarini, D.; Milzani, A.; Dalle-Donne,
I.; Rossi, R. J. Chromatogr., B. 2007, 851, 124. (g) Gladwin, M. T.; Wang,
X.; Hogg, N. Free Radical Biol. Med. 2006, 41, 557.
(3) (a) Wang, H.; Xian, M. Angew. Chem., Int. Ed. 2008, 47, 6598. (b) Zhang,
J.; Wang, H.; Xian, M. J. Am. Chem. Soc. 2009, 131, 3854. (c) Zhang, J.;
Wang, H.; Xian, M. Org. Lett. 2009, 11, 477.
(4) (a) Haake, M. Tetrahedron Lett. 1972, 33, 3405. (b) Reisz, J. A.; Klorig,
E. B.; Wright, M. W.; King, S. B. Org. Lett. 2009, 11, 2719.
(5) This process is similar to the well-known Staudinger ligation: (a) Saxon,
E.; Bertozzi, C. R. Science 2000, 287, 2007. (b) Lin, F. L.; Hoyt, H. M.;
van Halbeek, H.; Bergman, R. G.; Bertozzi, C. R. J. Am. Chem. Soc. 2005,
127, 2686. (c) Nilsson, B. L.; Kiessling, L. L.; Raines, R. T. Org. Lett.
2000, 2, 1939.
(6) (a) Lovas, F. J.; Suenram, R. D.; Stevens, W. J. J. Mol. Spectrosc. 1983,
100, 316. (b) Inagaki, Y.; Okazaki, R.; Inamoto, N. Bull. Chem. Soc. Jpn.
1979, 52, 3615. (c) Barton, D. H. R.; Ley, S. V.; Magus, P. D. J. Chem.
Soc., Chem. Commun. 1975, 855.
(7) (a) McLachlin, D. T.; Chait, B. T. Anal. Chem. 2003, 75, 6826. (b) Oda,
Y.; Nagasu, T.; Chait, B. T. Nat. Biotechnol. 2001, 19, 379.
(8) For selected reviews, see: (a) Williams, D. L. H. Acc. Chem. Res. 1999,
32, 869. (b) Wang, P. G.; Xian, M.; Tang, X. J; Wen, Z.; Cai, T. W. Chem.
ReV. 2002, 102, 1091. (c) Szacilowski, K.; Stasicka, Z. Prog. React. Kinet.
Mech. 2001, 26, 1.
(9) Bernardes, G. J. L.; Grayson, E. J.; Thompson, S.; Chalker, J. M.; Errey,
J. C.; El Oualid, F.; Claridge, T. D. W.; Davis, B. G. Angew. Chem., Int.
Ed. 2008, 47, 2244.
JA905558W
9
J. AM. CHEM. SOC. VOL. 131, NO. 37, 2009 13239